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The intestinal immune system has the daunting task of protecting us from pathogenic insults while limiting in-
flammatory responses against the resident commensal microbiota and providing tolerance to food antigens.
This role is particularly impressive when one considers the vast mucosal surface and changing landscape
that the intestinal immune systemmustmonitor. In this review,we highlight regional differences in the develop-
ment and composition of the adaptive immune landscape of the intestine and the impact of local intrinsic and
environmental factors that shape this process. To conclude, we review the evidence for a critical window of
opportunity for early-life exposures that affect immunedevelopment and alter disease susceptibility later in life.Introduction
The intestine is a long tube-like structure stretching from the
oral cavity to the anus, and its primary functions are to digest
food, absorb nutrients and water, and eliminate waste. The in-
testine also represents a major site of entry for many bacterial
and viral pathogens and is home to a vast and diverse microbial
community increasingly recognized to have a major impact on
host physiology and pathophysiology. This constantly changing
and dynamic environment represents a key challenge to the im-
mune system. It is thus perhaps unsurprising that the intestine
contains the greatest number and diversity of immune cells in
the body.
The intestine should not be viewed as a single homoge-
neous organ but rather as consisting of several anatomically
and functionally specialized segments with distinct envi-
ronmental pressures (for a review, see Mowat and Agace,
2014). To maintain local tissue homeostasis, different intes-
tinal segments have adopted unique defense strategies,
including alterations in epithelial subset composition and func-
tion, mucus layer integrity, and regionalized immune system
specialization. Continual crosstalk between environmental sig-
nals and the immune system is essential for maintaining local
tissue homeostasis, and alterations in such signals (e.g., from
nutritional deficiencies or alterations in microbial composition
[dysbiosis]) can rewire immune cell composition and function-
ality, resulting in chronic inflammation and increased risk for
infection.
Here, we highlight the contribution of luminal signals in
shaping and maintaining regional adaptive immune cell compo-
sition and function in the intestine. We further discuss the early
environmental factors affecting intestinal immune system devel-
opment and their long-term impact on health. Collectively, such
studies highlight the importance of the environment in maintain-
ing local immune homeostasis and the potential of modulating
such signals in early-life and inflammatory settings for improving
human health.532 Immunity 46, April 18, 2017 ª 2017 Elsevier Inc.Regional Differences in Intestinal Anatomy, Function,
and Luminal Content
Thesmall intestine,whoseprimary function is in nutrient digestion
and absorption, starts at the pylorus directly downstream of the
stomachand terminates at the ileocaecal valve. In humans, it rea-
ches 6–7m in length and consists of the duodenum, jejunum, and
ileum in descending order. The surface is characterized by long
finger-like projections called villi, which become progressively
shorter and broader down the small intestine. Villi are surrounded
by intestinal crypt invaginations, termed the crypts of Lieberk€uhn,
that contain the multi-potent epithelial stem cells that give rise to
the various epithelial lineages covering the intestinal surface. The
base of these crypts, particularly in the ileum, is home to special-
ized epithelial cells, termed Paneth cells, that produce a range of
antimicrobial peptides that serve to protect the sterility of the
crypt, as well as epithelial growth factors that regulate stem cell
differentiation and function. Absorptive epithelial cells, termed
enterocytes, coat the villi; their apical surface is covered with
microvilli that form a ‘‘brush border’’ for optimal digestion and
absorption of foodstuffs. In addition to the luminal content from
the stomach, the duodenum receives 0.6–1.0 L of bile per day
through the common bile duct. The major constituents of bile
include cholesterol, lecithin, bilirubin, and bile salts, the latter of
which provide a key detergent action on fat particles in the
food and aid in the adsorption of fatty acids, monoglycerides,
cholesterol, and other lipids. Absorption of mono-, di-, and tri-
saccharides, amino acids, dietary fat, and fat (vitamins A, D, E,
and K)- or water (vitamins B and C)-soluble vitamins occurs pri-
marily in the duodenum and jejunum, whereas the ileum serves
as a major site of bile salt and vitamin B12 absorption. Because
many of these luminal constituents have immune-modulatory ac-
tivity, their varying concentrations along the lengthof the intestine
are likely to have an important impact on regulating regionalized
immune cell compartmentalization and functionality.
The ileocecal valve opens into the large intestine, which (in hu-
mans) is composed of the caecum (and associated blind-ended
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colon, and the rectum, and it terminates at the anal canal. The
human colon is considerably shorter (approximately 1.5 m) and
wider than the small intestine. Although also covered by a single
layer of columnar epithelial cells, its surface consists entirely of
crypts interspersed between flat regions of surface epithelium.
Mucus-producing goblet cells make up a relatively small per-
centage (%10%) of epithelial cells in the small intestine but
represent R25% of epithelial cells in the large intestine. As a
result, the mucous layer, termed the glycocalyx, is diffuse and
permeable to bacteria in the small intestine but forms a thick
bi-layered structure in the colon, whose inner layer is virtually
impenetrable to bacteria. Although the majority of dietary con-
stituents are absorbed in the small intestine, approximately
1.5 L of intestinal fluid passes through the ileocecal valve each
day. This fluid consists primarily of water and electrolytes,
most of which are absorbed in the upper half of the colon, as
well as semi- or undigested foodstuffs, including plant polysac-
charides and fiber, which serve as an essential nutritional source
for resident microbiota.
The intestinal microbiome plays an essential role in host health
and, particularly in the context of this review, in modulating local
adaptive immune cell development, composition, and function.
Microbial density increases from the upper to the lower gastroin-
testinal tract until it reaches its peak in the colon, which contains
the highest microbial diversity and load. The mechanisms by
which the microbiota modulates the intestinal immune system
is under intense investigation but include (1) direct microbial in-
teractions with host cells and (2) bacterial generation of immune
modulatory molecules either through modification of dietary
metabolites or through de novo production. The relative impact
of these pathways in modulating immune homeostasis will vary
along the length of the intestine depending on local variations
in surface physiology (e.g., mucus integrity), microbial load,
and microbial diversity.
Regionalized Variation in Intestinal Inductive
Compartments
The intestine is composed of four major layers: the mucosa, the
submucosa, the muscularis, and the serosa. The mucosa, which
is proximal to the intestinal lumen, consists of a single layer
of columnar epithelial cells and an underlying lamina propria
(LP) and contains the vast majority of immune cells. Immune
cells are located within organized lymphoid structures, termed
gut-associated lymphoid tissues (GALTs), embedded within
the intestinal LP and sub-mucosa or are diffusely distributed
throughout the epithelium and LP. GALTs, together with intesti-
nal draining lymph nodes (LNs), serve as the major sites of adap-
tive immune cell priming in the intestine. GALTs include the
macroscopically visible Peyer’s patches (PPs) of the small in-
testine, caecal patches, colonic patches, and smaller struc-
tures collectively referred to as solitary isolated lymphoid tissues
(SILTs), which include cryptopatches (CPs) and more mature
isolated lymphoid follicles (ILFs) (Hamada et al., 2002; Pabst
et al., 2005). In humans, PPs are primarily located in the terminal
ileum; their numbers peak in the midteens (approximately 250)
and then wane with age (Cornes, 1965). Additional large GALT
structures are found throughout the appendix. Although CPs
have not been identified in the human intestine, there are an esti-mated 30,000 ILFs, whose highest densities are in the ileum and
distal colon (Moghaddami et al., 1998; O’Leary and Sweeney,
1986). Large GALT structures in mice include PPs, which are
more numerous in the distal small intestine, a single large
GALT in the caecum (the caecal patch), and two to five colonic
patches (Baptista et al., 2013; Masahata et al., 2014). Mice
also have 1,000–1,500 SILTs distributed throughout the small
intestine and mature SILTs concentrated in the ileum, consistent
with the finding that SILT maturation in the small intestine re-
quires signals from the microbiota (Herbrand et al., 2008).
Although SILT numbers in the colon have yet to be enumer-
ated, they appear more abundant in the distal colon (Baptista
et al., 2013).
GALTs lack afferent lymphatics and sample luminal particulate
antigens through specialized microfold (M) cells located within
an overlying follicular-associated epithelium. Antigens sampled
through M cells are subsequently taken up by antigen-pre-
senting cells in the underlying sub-epithelial dome of GALTs
for processing and presentation to lymphocytes. In contrast,
adaptive immune cell priming in intestinal draining LNs involves
the transport and presentation of luminal or self-derived anti-
gen by LP-derived migratory dendritic cells (DCs) (Macpherson
and Uhr, 2004). Several mechanisms by which DCs acquire
luminal antigen in the LP have been proposed, including (1) direct
antigenic uptake via goblet-cell-associated antigen passages
(McDole et al., 2012) or trans-epithelial extended DC-derived
dendrites (Farache et al., 2013; Rescigno et al., 2001) or (2) indi-
rect uptake via tissue-resident macrophages (Mazzini et al.,
2014), apoptotic epithelial cells (Huang et al., 2000), or villous
M cells (Jang et al., 2004). The relative contribution of these path-
ways in adaptive immune cell priming, and whether differential
antigen uptake results in distinct adaptive immune responses,
remains unclear.
Development of the Inductive Sites in the Intestine
The development of PPs is initiated during fetal life and is guided
by intrinsic and programmed events, although maturation is
completed postnatally and is influenced by external factors. In
contrast, CPs and ILFs develop and mature after birth. In addi-
tion, the development of GALT structures in the small intestine
and colon is guided by different signals.
In mice, the development of PPs and colonic patches is
initiated on embryonic day 12.5 (Adachi et al., 1998). For PPs,
the primary event is initiated by CD45+CD4CD3CD127
cKit+CD11c+ lymphoid tissue initiator (LTin) cells expressing
LTb and RET (Fukuyama and Kiyono, 2007; Veiga-Fernandes
et al., 2007) (Figure 1A). Stimulation of LTin cells by the RET
ligand artemin (ARTN) expressed on VCAM-1+ stromal cells
initiates upregulation of LTa1b1 and clustering of LTin cells, re-
sulting in activation of lymphoid tissue organizer (LTo) cells and
recruitment of lymphoid tissue inducer (LTi) cells (Patel et al.,
2012). In PPs, this initial event is dependent on RET and cellular
adhesion but not on chemokines. It is not yet clear whether RET
signaling is also involved in the development of colonic patches.
LTi cells originate in the fetal liver, although recently the fetal gut
has been shown to contain pre-LTi (IL-7Ra+CD4RORgt) and
LTi0 (IL-7Ra
+CD4RORgt+) cells that mature locally in response
to retinoic acid (RA) signaling (van de Pavert et al., 2014).
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Figure 1. Pre- and Postnatal Development of GALTs
(A) PP development in the small intestine is initiated prenatally after interaction betweeen LTb+RET+ LTin cells and ARTN-producing VCAM-1+ICAM-1+ LTo
stromal cells. LTb interaction with LTbR upregulates VCAM-1 and ICAM-1 expression on LTo cells and stimulates production of cytokines CCL19, CCL21,
CXCL13, and IL-7, the latter of which recruits IL-7Ra+ LTi cells and upregulates LTa1b1 expression. It is not known whether LTb+RET+ LTin cells are required for
the development of colonic patches.
(B) CPs and ILFs develop postnatally in the colon and small intestine. CPs form first as clusters of LTi cells with CD11c+ cells and survive and expand in response
to AhR ligands. In the small intestine, the transition of CPs to immature ILFs requires RANKL and CXCL13 and microbial stimulation of NOD1 on epithelial cells,
leading to the production of CCL20 and mBD3, ligands of CCR6. Further maturation involves NOD2 and the adaptor molecule MyD88. In the colon, the transition
of CPs to ILFs does not require CXCL13, RANKL, CCR6, or the microbiota. Here, IL-23 production from CD11c+ cells in the CPs drives maturation, which is
inhibited by the IL-25 that is produced by epithelial cells in response to the microbiota.
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the intrinsic and programmed events that guide PP develop-
ment, maternal dietary signals can also play a role (van de Pavert
et al., 2014).
In PPs and colonic patches, LTbR signaling on LTo cells
leads to activation of NFkb (Dejardin et al., 2002) and stimu-
lates expression of intercellular adhesion molecule 1 (ICAM-1),
vascular cell adhesion molecule 1 (VCAM-1), mucosal vascular
addressin cell adhesion molecule 1 (MadCam-1), CXCL13,
CXCL12, CCL19, CCL21, and IL-7 (Be´ne´zech et al., 2010; Cu-
pedo et al., 2004; Dejardin et al., 2002; Vondenhoff et al., 2009).
These interactions create a positive-feedback loop leading to
further recruitment of IL-7Ra+ LTi and other hematopoietic cells,
including B and T cells. IL-7Ra signaling on LTi cells is necessary
for PP development (Adachi et al., 1998; Luther et al., 2003;
Yoshida et al., 1999). Whereas B and T cells are rapidly recruited534 Immunity 46, April 18, 2017to small intestinal PPs during development, recruitment to the
colonic patches is delayed (Baptista et al., 2013), suggesting dif-
ferential signaling between the small intestine and the colon.
In mice, CPs and ILFs develop postnatally in a process that is
influenced by dietary and microbial factors, whereas in humans,
ILFs are present before birth (Hoorweg and Cupedo, 2008). In
mice, CPs form around day 14 after birth and first appear as
clusters of LTi cells surrounded by CD11c+ cells (Figure 1B).
Themicrobiota appears not to be required for CP formation given
that such structures also form in germ-freemice (Kanamori et al.,
1996). In contrast, CPs are severely reduced in the absence of the
aryl hydrocarbon receptor (AhR), most likely because of a lack of
expansion or survival of RORgt+ innate lymphoid cells (ILCs) (Kiss
et al., 2011; Lee et al., 2011). Natural AhR ligands can be endog-
enous, provided through diet, or produced by the microbiota
through tryptophan metabolism (Cella and Colonna, 2015).
Immunity
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stromal cell expression of the receptor activator of nuclear factor
kappa-B ligand (RANKL), which stimulates CXCL13 production
by stromal cells andCD11c+ DCs (Knoop et al., 2011). Deficiency
of either CXCL13 or CXCR5 leads to an absence of ILFs (but not
CPs) in the small intestine (McDonald et al., 2010; Velaga
et al., 2009). In contrast, colonic ILFs do not require RANKL or
CXCL13 for development (Baptista et al., 2013; Knoop et al.,
2011). The transition of CPs to immature ILFs in the small intes-
tine occurs in response to peptidoglycan (PGN) derived from
gram-negative bacteria. PGN ligation of nucleotide-binding olig-
omerization domain-containing protein 1 (NOD1) on epithelial
cells leads to secretion of CCL20 and b-defensin 3 (mBD3),
which are both ligands for CCR6, and a deficiency of CCR6,
CCL20, or mBD3 leads to loss of ILFs in the small intestine (Bou-
skra et al., 2008). Further maturation is then stimulated by activa-
tion of Toll-like receptors (TLRs), myeloid differentiation factor 88
(MyD88), and NOD2 (Bouskra et al., 2008). In contrast to the
small intestine, the colon of germ-free mice harbors immature
and mature ILFs, indicating that, despite the increased bacterial
load of the colon, microbial-derived signals are not essential for
their development (Baptista et al., 2013; Donaldson et al., 2015).
Nevertheless, the microbiota is still able to regulate colonic ILFs.
For example, the number of ILFs in the colon is increased in
NOD1-deficient mice (Bouskra et al., 2008), suggesting that
NOD1-independent pathways can stimulate colonic ILF devel-
opment. Chemokine and cytokine involvement in ILF develop-
ment also differs between the small intestine and colon; colonic
ILFs are present in CCR6-deficient mice (Baptista et al., 2013),
indicating that the CCR6-CCL20 pathway is less important
in the colon. In addition, despite their presence in germ-free
mice, mature colonic ILFs still require the adaptor molecule
MyD88 (Baptista et al., 2013), suggesting that signaling through
members of the IL-1R family rather than TLRs could be important
at this site. Furthermore, IL-23 has been shown to be a colon-
specific regulator of ILFs, which is supported by the observation
that IL-23p19-deficient mice show a specific reduction in colonic
ILFs (Donaldson et al., 2015). Microbial stimulation of epithelial
cells leads to IL-25 production, which then inhibits IL-23 expres-
sion by CD11c+ cells enriched with colonic ILFs (Donaldson
et al., 2015). Although microbiota stimulate IL-25 production in
both the small and large intestines, tissue specificity of the
response could be due to the scarcity of the IL23-expressing
CD11c+ cells in small intestinal ILFs.
Regionalized Variation in Intestinal Adaptive Immune
Cell Effector Compartments
The intestinal epithelium and underlying LP are the major sites
of adaptive immune cell accumulation within the intestine.
Although the overwhelming majority of adaptive immune cells
in the epithelium are CD8+ intraepithelial lymphocytes (IELs)
(Cheroutre and Madakamutil, 2004), the LP contains large
numbers of functionally diverse CD4+ T cell subsets and plasma
cells (PCs) and a relatively minor fraction of CD8+ T cells. Collec-
tively, these cells play an essential role in maintaining intestinal
homeostasis; however, their composition differs markedly be-
tween distinct intestinal segments. Below, we highlight some
of themajor differences in adaptive immune cell composition be-
tween intestinal segments to emphasize the importance of localsignals in shaping regional immune specialization. Most studies
have been performed in mice, and although it is tempting to
extrapolate such findings to the human setting, far more work
is required for assessing variations in immune cell subset
composition within different segments of the human intestine un-
der distinct physiological and pathophysiological conditions.
Variations in IEL Composition along the Length of the
Intestine
IELs can be broadly divided into two major subsets: type A and
type B, the proportions of which vary with age, species, and
location along the length of the intestine (Figure 2). Type A IELs
derive from conventional naive CD8ab+TCRab+ or CD4+TCRab+
T cells that have undergone activation in GALTs or LNs and
subsequently homed to the intestine to generate an epithelial
resident effector memory T cell population. Type b IELs, on the
other hand, do not express CD8b or CD4; instead, they express
the CD8aa homodimer and either an ab or gdTCR. CD8aa+
TCRab+ IELs are autoreactive and appear to derive from
agonist-selected double-positive thymocytes that seed the
epithelium as CD4CD8 cells, where they upregulate CD8aa
(Gangadharan et al., 2006; Leishman et al., 2002; Pobezinsky
et al., 2012). The origin of CD8aa+TCRgd+ IELs is less clear,
although recent evidence suggests that Vg7+ IELs, representing
the major population of TCRgd IELs in mice, undergo selective
maturation and expansion within the intestine (Di Marco Barros
et al., 2016). In both humans and mice, IEL numbers are greatest
in the proximal small intestine and decrease down the length of
the intestine. In mice, type B IELs represent a larger fraction of
the IEL compartment in the small intestine than in the colon,
whereas in humans, type B IELs represent only a minor fraction
of IELs in each intestinal segment (Beagley et al., 1995; Boll et al.,
1995; Camerini et al., 1993; Ibraghimov and Lynch, 1994;
Lundqvist et al., 1995; Suzuki et al., 2002).
Germ-free mice have a marked reduction in IELs, particularly
type A IELs (Bandeira et al., 1990; Kawaguchi et al., 1993; Suzuki
et al., 2002), most likely as a result of reduced lymphoid tis-
sue maturation and antigen-dependent naive T cell priming.
The mechanism(s) by which the microbiota promote type B IEL
homeostasis is less clear but could include bacterial-mediated
NOD2-dependent IL-15 productionby intestinal antigen-present-
ing cells (Jiang et al., 2013). Although the role of MyD88 in IEL ho-
meostasis remains controversial (Iiyama et al., 2003; Ismail et al.,
2011; Qiu et al., 2016; Yu et al., 2006), bacterial-induced MyD88
signaling in small intestinal epithelial cells appears important in
maintaining type B TCRgd IEL functionality (Ismail et al., 2011).
Germ-free mice still have large numbers of type B IELs and
maintain a bias for these cells in the small intestine (Suzuki
et al., 2002), indicating a role for additional tissue-specific
cues in regulating regionalized IEL subset composition
(Figure 2). One such factor is the chemokine CCL25. CCL25 is
constitutively expressed by epithelial cells in the small intestine
but not the colon (Kunkel et al., 2000; Svensson et al., 2002),
and its expression, which is microbiota independent, decreases
from the proximal to the distal small intestine (Ericsson et al.,
2004; Stenstad et al., 2007). Mice deficient in CCL25 or its recep-
tor CCR9 have reduced numbers of small intestinal IELs and
TCRgd IEL in particular (Wurbel et al., 2007; Wurbel et al.,
2001). The CCL25-CCR9 axis is also required for optimalImmunity 46, April 18, 2017 535
Figure 2. Factors Implicated in Regulating Intraepithelial Lymphocyte Composition along the Length of the Intestine
CCL25 is constitutively expressed by epithelial cells in the small intestine, but not the colon, particularly in the proximal small intestine. CCL25 recruits CCR9-
expressing IEL precursors from the blood stream into the small intestinal epithelium.
(A) Most type A IELs derive from naive conventional CD4+ or CD8ab+ T cells that acquire CCR9 expression after their activation in small intestinal inductive sites
and exposure to RA. CD8ab+ recent thymic emigrants also express CCR9 and can gain direct access to the small intestinal epithelium. RA is also required for the
conversion of CD4+ type A IELs into MHCII-restricted cytotoxic CD4+CD8aa+ IELs.
(B) CCR9-expressing type B IEL precursors are recruited directly from the thymus, although somemight undergo prior circulation and activation in small intestinal
GALTs and acquire higher expression of CCR9. After their entry into the small intestinal epithelium, type B IEL numbers are maintained by multiple local factors,
including (1) microbial-derived NOD ligands that drive resident antigen-presenting cells to produce IL-15, a proliferation and survival factor for type B IEL; (2)
selective expression of BTNL1 by small intestinal epithelial cells to promote Vg7+ IEL maturation and proliferation; (3) GPR18 ligands that promote type B IELs,
particularly Vg7+ IEL maturation; and (4) AhR ligands that directly promote type B IEL survival.
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hansson-Lindbom et al., 2003; Svensson et al., 2002; Wurbel
et al., 2007), especially the proximal small intestine (Stenstad
et al., 2007). CCR9 is induced onCD8ab+ T cells during their acti-
vation in intestinal inductive sites (Johansson-Lindbom et al.,
2003; Svensson et al., 2002), a process that is dependent on
the vitamin A metabolite RA (Iwata et al., 2004; Jaensson-Gyl-
lenb€ack et al., 2011; Svensson et al., 2008). Vitamin A obtained
through diet is found at higher concentrations in the small intes-
tine than in the colon (Jaensson-Gyllenb€ack et al., 2011) and is
locally converted to RA by small intestinal epithelial cells
(McDonald et al., 2012) and local stromal cells (Vicente-Suarez
et al., 2015). DCs in the small intestine constitutively receive
stronger RA signals than do colon DCs (Jaensson-Gyllenb€ack
et al., 2011), imprinting them with an ability to generate RA
and, after their migration to intestinal draining LNs, induce536 Immunity 46, April 18, 2017CCR9 on responding T cells. Some typeB IEL precursors, partic-
ularly Vg7+ T cells, can also proliferate and acquire enhanced
CCR9 expression in small intestinal GALTs prior to their entry
into the small intestinal epithelium (Guy-Grand et al., 2013). RA
is also required for the differentiation of CD4+ type A IELs into
major histocompatibility complex II (MHCII)-restricted cytotoxic
CD4+CD8aa+ IELs (Reis et al., 2014). Indeed, given the pleio-
tropic effects of RA on immune cells, its broader impact on small
intestinal IEL functionality warrants further study.
The butyrophilin-like (btnl) molecules are an additional family
of mediators involved in regulating region-specific lymphocyte
composition in epithelial tissues (Abeler-Do¨rner et al., 2012).
Murine BTNL1, BTNL4, and BTNL6 are selectively expressed
in the small intestine by post-mitotic enterocytes; BTNL1 is pre-
dominately present in the proximal and middle segments of
the small intestine and reaches maximal expression 14 days
Immunity
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ocyte-expressed BTNL1 is required for the maturation and
proliferation of Vg7+ IELs after their entry into the epithelium, a
process that is independent of the thymus, the microbiota, and
dietary proteins (Di Marco Barros et al., 2016). Induced expres-
sion of a Btnl1 transgene in young (7- or 21-day-old) but
not adult (11-week-old) Btnl1-deficient mice rescues Vg7+
IEL proliferation and numbers, suggesting that BTNL1-medi-
ated Vg7+ IEL proliferation is temporally restricted to early
life. G-protein-coupled receptor 18 (Gpr18)-deficient mice also
have reduced numbers of small intestinal IELs, particularly
Vg7+ IELs (Wang et al., 2014). Similar to BTNL1, GPR18 appears
to function after gd+ T cell entry into the epithelium, and gd+ IELs
in Gpr18-deficient mice appear immature (Wang et al., 2014).
Although the identity of the GPR18 ligand(s) remains unclear,
these results indicate that GPR18 could function to promote
Vg7+ IEL interactions with BTNL1-expressing enterocytes. Inter-
estingly, although the genetic locus encompassing Btnl1 and
Btnl6 is lacking in humans, BTNL3 and BTNL8 are constitutively
expressed by epithelial cells in the human colon, and in vitro
studies indicate their potential role in supporting human Vg4+
IEL maturation (Di Marco Barros et al., 2016).
Finally, a major dietary determinant of type B IEL homeostasis
is dietary AhR ligands (Li et al., 2011). Mice deficient in AhR have
a selective reduction in type B IELs in the small intestine. Wild-
type mice fed a synthetic diet have reduced numbers of type B
IELs, but these can be restored by dietary supplementation
with the AhR ligand precursor indole-3-carbinol (I3C). Mechanis-
tically, direct AhR signaling in IELs appears important for type B
IEL survival after their entry into the epithelium. Whether AhR
signaling contributes to type B IEL homeostasis in other parts
of the intestine remains to be explored.
Regional Compartmentalization of LP CD4+ T Cell
Subsets
The selective induction of homing molecules in intestinal induc-
tive sites is a major contributor to the generation of regionalized
LP T cell compartments. CCR9 induction on CD4+ and CD8+
T cells after activation in small intestinal inductive sites promotes
their homing to the small intestinal LP, particularly to the proximal
small intestine (Campbell and Butcher, 2002; Stenstad et al.,
2006; Stenstad et al., 2007; Svensson et al., 2002). Conversely,
the G-protein-coupled receptor GPR15 is expressed on colonic
but not small intestinal T cells, and in mice, it promotes effector
and regulatory T cell recruitment to the colonic LP (Kim et al.,
2013; Nguyen et al., 2015). In contrast to CCR9, where and
how activated T cells acquire expression of GPR15 remains un-
clear, although it is attractive to speculate that this could occur in
colonic GALT or colon draining LNs. Administration of broad-
spectrum antibiotics in mice reduces GPR15 expression on
colonic T cells (Kim et al., 2013), and SCFAs induce expression
of GPR15 on anti-CD3-treated human CD4+ T cells in vitro
(Fischer et al., 2016), suggesting a potential role for the micro-
biota in GPR15 induction. The GPR15 ligand(s) mediating T cell
recruitment to the colon are unknown, although GPR15-depen-
dent T cell homing to the colon is unaffected in germ-free
mice, indicating that the ligands are not microbial derived (Kim
et al., 2013). In contrast to murine GPR15, the human protein is
expressed on intestinal effector cells but not Foxp3+ Treg cells,suggesting that GPR15 is a potential target for the treatment of
colitis (Fischer et al., 2016; Nguyen et al., 2015).
Although distinct homing pathways help focus effector and
regulatory T cell responses to the small intestine or colon, there
are also marked differences in the composition of LP T helper
(Th) subsets, particularly in the proportions of FoxP3+ Treg and
Th17 cells along the length of the mouse intestine. The propor-
tions of FoxP3+ Treg cells in the intestinal LP are higher than in
other tissues; they range from 10%–20% of CD4+ T cells in the
small intestine and 20%–40% in the colon, depending on
housing conditions. Strikingly, Foxp3+ Treg cell numbers are
reduced in the colon but not small intestine of germ-free or anti-
biotic-treated mice (Atarashi et al., 2011; Geuking et al., 2011),
whereas germ-free mice fed an antigen-free diet have dramati-
cally reduced numbers of small intestinal FoxP3+ Treg cells
(Kim et al., 2016a). Thus, most FoxP3+ Treg cells in the small in-
testine appear to develop in response to dietary antigens,
whereas a large proportion of colonic FoxP3+ Treg cells develop
in response to the microbiota. During homeostasis, LP FoxP3+
Treg cells can be divided into two major subsets: (1) FoxP3+
Treg cells that co-express neuropilin 1 (NRP1) and Helios and
are believed to primarily consist of thymically derived natural
(n)Treg cells and (2) HeliosNRP1FoxP3+ Treg cells that
appear to represent peripherally induced Treg (pTreg) cells.
pTreg cell subsets can be further divided into RORgt-expressing
FoxP3+pTreg cells and RORgtFoxP3+ pTreg cells (Ohnmacht
et al., 2015; Sefik et al., 2015; Yang et al., 2016). RORgt+FoxP3+
pTreg cells represent the major FoxP3+ Treg cell subset in the
colon and, in contrast to natural Treg (nTreg) or RORgtFoxP3+
pTreg cells, are dramatically reduced in germ-free mice or after
antibiotic treatment, suggesting that they develop in response
to the microbiota (Kim et al., 2016a; Ohnmacht et al., 2015; Sefik
et al., 2015; Yang et al., 2016). Consistent with this, mono-colo-
nization of germ-free mice with bacteria from a range of phyla
and genera induces colonic RORgt+FoxP3+ pTreg cell genera-
tion, albeit to varying degrees (Sefik et al., 2015); a dominant
species possessing such activity in both humans and mice ap-
pears to be the Clostridia that promote mucosal TGFb produc-
tion and RORgt+FoxP3+ pTreg cell generation independently of
MyD88 (Atarashi et al., 2013; Atarashi et al., 2011; Ohnmacht
et al., 2015). Interesting, RORgt+FoxP3+ Treg cell numbers are
also reduced in IL-6- and IL23a-deficient mice, suggesting that
they follow a developmental pathway at least partially overlap-
ping that of Th17 cells (Ohnmacht et al., 2015). The microbiota
has also been suggested to maintain the intestinal nTreg cell
niche under conditions of pTreg cell deficiency in anMHCII-inde-
pendent manner (Korn et al., 2014). In contrast, RORgtFoxP3+
pTreg cells dominate in the small intestine and represent only a
minor proportion of FoxP3+Treg cells in the colon, and their
numbers are selectively reduced in mice fed an antigen-free
diet, suggesting that they develop in response to dietary antigen
(Kim et al., 2016a). Global absence of FoxP3+pTreg cells in the
intestine results in spontaneous allergic Th2-type inflammation
along the length of the intestine (Josefowicz et al., 2012);
however, RORgt+ and RORgt pTreg cell subsets appear to
play distinct roles in maintaining homeostasis given that the
specific absence of RORgt+FoxP3+ pTreg cells results in
enhanced intestinal Th2 (Ohnmacht et al., 2015) or Th17 and
Th1 cell responses (Sefik et al., 2015), whereas the absence ofImmunity 46, April 18, 2017 537
Figure 3. Impact of Environmental Signals
on the Generation and Distribution of
Peripherally Induced FoxP3+ Treg Cells
(A) FoxP3+ Treg cells, although found throughout
the intestinal LP, are highest in number in the colon
and inversely correlate with intestinal Th17 cell
numbers. FoxP3+ Treg cells can be divided into
Helios+NRP1+ thymically derived nTreg cells and
HeliosNRP1 pTreg cells. pTreg cells can be
further divided into RORgt+pTreg cells, which are
heavily dependent on the microbiota and domi-
nate in the colon, and RORgtpTreg cells, which
are dependent on dietary antigen and dominate in
the small intestine. Dietary or microbial-derived
vitamin B9 signals through folate receptor 4 (FR4)
to promote FoxP3+ Treg cell survival in the intes-
tinal LP. FoxP3+ Treg cell and effector CD4+ T cell
migration to the small intestine involves the
CCL25-CCR9 axis, whereas FoxP3+ Treg cell
(mouse only) and effector CD4+ T cell migration to
the colon is mediated by GPR15, whose ligands
remain to be determined.
(B) pTreg cells are generated from naive CD4+
T cells in intestinal inductive sites, and their
development requires MHCII expression by
CD11c+ DCs. The generation of pTreg cells is
enhanced by environmental signals acting directly
on CD4+ T cells during their differentiation or
indirectly on DCs promoting their tolerogenic ca-
pacity. For RORgt+ pTreg cells, such signals
includemicrobial-dependent MyD88 signaling and
SCFA signaling in T cells to promote FoxP3 tran-
scription and potentially expression of the colon
homing receptor GPR15. Generation or mainte-
nance of RORgt+pTreg cells also requires IL-6 and
IL-23, which promote RORgt expression, and RA,
which promotes FoxP3 expression and could
prevent these cells from differentiating to the Th17
cell lineage. The ability of DCs to drive FoxP3+ Treg
cell differentiation is promoted by RA, which in a
feed forward loop enhances the capacity of DCs to
make RA and vitamin B3 (niacin), which functions
via GPR109a, to reduce the inflammatory potential
and promote the regulatory potential of these cells.
Butyrate signals through GPR109a in a similar
manner or in a G-protein-coupled-independent
manner to downregulate RelB expression and
enhance the Treg-cell-driving capacity of DCs.
The generation of RORgt pTreg cells is inde-
pendent of the microbiota, IL-6, and IL-23 but is
promoted by RA. RA synergizes with TGFb to drive
RORgtpTreg cell development and simulta-
neously induces expression of CCR9, priming
these cells with a small intestinal homing capacity.
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gen (Kim et al., 2016a).
In addition to providing a steady source of antigen, diet and
the microbiota support intestinal Treg cell homeostasis by a
wide variety of mechanisms, many of which remain incom-
pletely understood (for a recent review, see Tanoue et al.,
2016) (Figure 3). Direct microbiota-induced MyD88-dependent538 Immunity 46, April 18, 2017signaling in FoxP3+ Treg cells is important
for optimal pTreg cell induction potentially
via demethylation of conserved non-cod-
ing sequence 2 (CNS2) of the Foxp3
promotor, which is required for stable
Foxp3 expression. As a result, mice with
MYD88 deficiency specifically in FoxP3+Treg cells have reduced numbers of intestinal FoxP3+ Treg cells
(Wang et al., 2015). Short-chain fatty acids (SCFAs), bacterial
metabolites generated from the fermentation of undigested fiber
and present in high levels in the colon (Cummings et al., 1987),
also promote colonic FoxP3+Treg cell homeostasis. Butyrate
acts directly on CD4+ T cells to drive H3 acetylation of the
FoxP3 promotor and its CNS1 enhancer element, required for
Immunity
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et al., 2013), whereas propionate enhances pTreg cell generation
(Arpaia et al., 2013) and colonic nTreg cell proliferation and func-
tionality, the latter via GPR43 (Smith et al., 2013). Butyrate also
promotes FoxP3+ Treg cell generation indirectly through DCs,
either in a G-protein-coupled-receptor-independent manner to
suppress RelB and pro-inflammatory gene expression (Arpaia
et al., 2013) or via the butyrate and niacin (vitamin B3) receptor
GPR109a (Singh et al., 2014), enhancing their ability to drive de
novo FoxP3+ Treg cell differentiation. Consistent with the latter,
mice deficient in Niacr1 (which encodes GPR109a) display a
marked reduction of colonic but not small intestinal FoxP3+ Treg
cells (Singh et al., 2014). Certain commensals have also adapted
unique mechanisms to promote intestinal Treg cell homeostasis
and host-microbial mutualism. Perhaps the best characterized
mechanistically is polysaccharide A (PSA) from the human
commensal Bacteroides fragilis; it promotes IL-10 production by
intestinal FoxP3+ Treg cells via TLR2-dependent direct effects
on CD4+ T cells (Round and Mazmanian, 2010) or via indirect ef-
fectsonplasmacytoidDCs (Dasgupta et al., 2014) or conventional
DCs (Shen et al., 2012).
Several dietary metabolites that promote FoxP3+ Treg cell
generation have also been identified. In addition to inducing
CCR9 on pTreg cells, RA synergizes in vitro with TGFb to pro-
mote pTreg cell differentiation (Kang et al., 2007; Sun et al.,
2007), and consistent with this finding, mice kept on a vitamin-
A-deficient diet appear defective in the induction of oral toler-
ance (Cassani et al., 2011). RA also promotes the generation of
RORgt+FoxP3+ pTreg cells in vitro (Lochner et al., 2008), and
blocking RA signaling in vivo prevents the development of these
cells (Ohnmacht et al., 2015). Nevertheless, RA has pleiotropic
roles in regulating immune cell functionality (for a review see,
Brown and Noelle, 2015), and the direct role of RA signaling in
T cells for intestinal nTreg and pTreg cell homeostasis in vivo re-
mains to be determined. The water-soluble vitamin B subtype
vitamin B9 (folic acid [FA]) also affects FoxP3+ Treg cell homeo-
stasis. FA is obtained exclusively from diet or through the micro-
biota, and mice kept on an FA-deficient diet display a selective
reduction in intestinal FoxP3+ Treg cells (Kinoshita et al., 2012;
Kunisawa et al., 2012). Local concentrations of FA promote
FoxP3+ Treg cell survival through folate receptor 4, which is high-
ly expressed by FoxP3+ Treg cells (Kinoshita et al., 2012; Yama-
guchi et al., 2007). Although additional dietary derivatives have
been implicated in promoting Treg cell induction, most notably
tryptophan metabolites (Mezrich et al., 2010; Singh et al.,
2014) and the vitamin D3 metabolite 1-25 dihydroxyvitamin D3
(Kang et al., 2012), their impact on regionalized intestinal
FoxP3+ Treg cell homeostasis remains to be elucidated.
In mice, the total number and proportions of intestinal
Th17 cells along the length of the intestine inversely correlate
with those of FoxP3+ Treg cells, such that the highest Th17 cell
numbers are found in the proximal small intestine and steadily
decline toward the colon (Denning et al., 2011). Th17 cells are
virtually absent from the intestine of germ-freemice but are found
in normal numbers inMyd88/Trif/mice, demonstrating a key
role for the microbiota, but not TLR signaling, in intestinal Th17
cell homeostasis (Atarashi et al., 2008; Ivanov et al., 2008). Treat-
ment of mice with broad-spectrum antibiotics results in a severe
depletion of intestinal Th17 cells, suggesting that the microbiotais also critical formaintenance of the intestinal Th17 cell compart-
ment (Gaboriau-Routhiau et al., 2009; Ivanov et al., 2008). The
best characterized microbial inducer of intestinal Th17 cell re-
sponses is the gram-positive segmented filamentous bacteria
(SFB) (Ivanov et al., 2009). SFB adhere to epithelial cells in the ter-
minal ileum and drive a dramatic increase in Th17 cell numbers
within the ileal LP. Mechanistically, SFB induce an antigen-spe-
cific CD4+ T cell response that is heavily skewed toward the
RORgt+ Th17 cell lineage (Geem et al., 2014; Goto et al., 2014;
Yang et al., 2014) and dependent on MHCII expression by
CD11c+ cells (Geem et al., 2014; Goto et al., 2014) and mono-
cyte-derived macrophages (Panea et al., 2015). SFB-specific
Th17 cell differentiation can occur independently of GALT and
MLN (Geem et al., 2014; Le´cuyer et al., 2014) but most likely re-
quires the tertiary lymphoid tissues that develop as a result of
SFB colonization (Le´cuyer et al., 2014). Recent data suggest
that newly generated SFB-specific RORgt+ CD4+ T cells dissem-
inate throughout the gut (Sano et al., 2015) and that epithelial-
derived serum amyloid A (SAA) and reactive oxygen species
(ROS) promote IL-17 production by infiltrating RORgt+CD4+
T cells within the ileum (Atarashi et al., 2015; Sano et al., 2015).
SFB adherence to ileal epithelial cells is required for epithelial
SAA and ROS production, and amplification of this epithelial
SAA response through IL-23-dependent IL-22 production by
ILC3 and IL-1b production from LP CD11c+ cells is further
required to drive local IL-17 production by infiltrating
RORgt+CD4+ T cells (Atarashi et al., 2015; Sano et al., 2015).
The ability to induce Th17 responses is not, however, unique to
SFB but could be a general property of adherent commensal or
pathogenic microbes (Atarashi et al., 2015; Tan et al., 2016b),
whereby the site of intestinal IL-17+ CD4+ T cell accumulation
is determined by the location of the adherent microbe. In this re-
gard, it is interesting to speculate that easier access of adherent
microbes to the small intestinal epithelium underlies the
enhanced numbers of Th17 cells within this region of the intes-
tine. Finally, although direct epithelial adherence appears key
to the efficient generation of Th17 responses, the downstream
molecular mechanisms driving this response are likely to be
microbe specific (Atarashi et al., 2015; Tan et al., 2016b).
Given the key role of the microbiota in intestinal Th17 cell
homeostasis, it is not surprising that dietary-induced changes
in microbial composition can alter intestinal Th17 cell numbers.
For example, alterations in microbial composition induced by a
high-fat diet drive changes in small intestinal antigen-presenting
cell functionality, resulting in reduced small intestinal Th17 cell
numbers (Garidou et al., 2015), whereas dietary supplementa-
tion with long-chain fatty acids (LCFAs) alters the microbial
composition by increasing levels of medium-chain fatty acids
and LCFAs and reducing SCFAs to promote small intestinal
Th17 development (Haghikia et al., 2015). Thus, bacterial com-
munities generating high concentrations of SCFAs promote in-
testinal Treg cell development, whereas those generating LCFAs
appear to favor Th17 cell development. Finally, luminal ATP also
appears to promote intestinal Th17 development (Atarashi et al.,
2008; Kusu et al., 2013).
Regional Compartmentalization of IgA+ PCs
An estimated 80% of human and mouse PCs are located in the
intestinal LP, and recent evidence suggests that they can beImmunity 46, April 18, 2017 539
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highest in the proximal and distal portions of the intestine, and
the overwhelming majority of these produce IgA (approximately
75%–80% of PCs in duodenum and jejunum and 90% of PCs in
the colon). In both mice and humans, intestinal IgA+ PCs repre-
sent a collection of low-frequency and expanded clones (Lindner
et al., 2012) that display specificity for the microbiota and self-
antigens (Benckert et al., 2011). Intestinal IgA plays an essential
role in establishing luminal microbial diversity and host-micro-
biota mutualism and contributes to preventing microbial access
to systemic compartments (Fagarasan et al., 2002). In contrast
to mice, which have one IgA subclass, humans have IgA1 and
IgA2; IgA1-producing PCs dominate in the small intestine, and
IgA2 PCs dominate in the colon (Crago et al., 1984; Kett et al.,
1986; Lin et al., 2014). Because protein antigens tend to drive
IgA1 responses and polysaccharides tend to drive the IgA2 sub-
class (Tarkowski et al., 1990), the differential distribution of these
subclasses along the length of the intestine could reflect alter-
ations in luminal content. Consistent with this, the dominance
of IgA1 in the small intestine is reversed to IgA2 under conditions
of bacterial outgrowth (Kett et al., 1995). IgA2 is also more resis-
tant to bacterial proteases, suggesting adaptation to the colonic
environment (Kilian et al., 1996; Plaut et al., 1974).
GALTs are considered the major sites of IgA class switching
(Barone et al., 2011; Brandtzaeg, 2009), which (in mice) optimally
requires M-cell-mediated uptake of luminal antigen (Rios et al.,
2016). Whereas in mice large GALTs have been considered the
primary site of T-cell-dependent IgA responses and ILFs the
primary site of T-cell-independent IgA responses (Tsuji et al.,
2008), it remains unclear whether this division of labor occurs
in humans.
Several host-derived factors promote class switching to IgA in
GALTs in vivo; the principal factor in mice is TGFb (Cazac and
Roes, 2000; van Ginkel et al., 1999). However, induction of IgA
class switching and PC generation is also highly dependent on
external diet- and microbial-derived signals (Figure 4). Germ-
free mice display a dramatic reduction in intestinal IgA PCs
(Crabbe´ et al., 1968). The mechanisms by which the microbiota
promotes IgA class switching and IgA PC generation in GALTs
are multifaceted and remain to be fully characterized. In addition
to providing relevant antigenic material and promoting GALT
development, the microbiota directly signals through MyD88 in
T cells to drive germinal center (GC) T follicular helper (TFH) cell
generation in PPs and subsequent T-cell-dependent secretory
IgA responses to the microbiota (Kubinak et al., 2015). Microbi-
al-driven MyD88-dependent iNOS induction in CD11c+ cells
also promotes T-cell-dependent IgA switching through the induc-
tion of TGFbRII on B cells and T-cell-independent IgA responses
through induction of a proliferation-inducing ligand (APRIL) and
B-cell-activating factor of the TNF family (BAFF) (Tezuka et al.,
2007). Additionally, SCFAs inhibit histone deacetylase (HDAC) in
B cells to enhance glycolysis and fatty acid synthesis and support
antibody production, and they appear to regulate the numbers of
IgA+ GCB cells in PPs and IgA+ PCs in the small intestine and co-
lon (Kim et al., 2016b). Finally, RA promotes IgA class switching
and IgA production in vitro (Mora et al., 2006; Watanabe et al.,
2010), and mice whose B cells are unresponsive to RA display a
marked reduction in IgA+ GC B cells in PPs and IgA+ PCs in the
small intestine (Pantazi et al., 2015). Notably, the SCFA acetate540 Immunity 46, April 18, 2017signals throughGPR43 in DCs to enhance their ability to generate
RA and promote IgA class-switch recombination and IgA pro-
duction in vitro (Wu et al., 2016). Whether RA displays a more
dominant role indriving IgAplasmablastgeneration in thesmall in-
testine than in the colon, as might be expected given the higher
concentrations of retinol in the small intestine (Jaensson-Gyl-
lenb€ack et al., 2011), remains to be determined.
IgAplasmacell clones are not evenly distributed throughout the
intestine; expanded clones detected throughout the small intes-
tine are infrequently found in the colon of the same mouse and
vice versa (Lindner et al., 2012). Such site-specific accumulation
of IgA PCs within distinct intestinal segments, as with T cells,
is likely to be regulated by differential expression of homing mol-
ecules (Figure 4). Consistent with this, RA-dependent CCR9
induction on IgA plasmablasts is required for optimal IgA PC
accumulation in the small intestine, but not the colon (Mora
et al., 2006; Pabst et al., 2004), and Ccr9 deficiency results in
an enhanced overlap of related expanded IgA clones between
the small intestine and colon (Lindner et al., 2012). IgA PCs also
express CCR10, whose ligand CCL28 is expressed by intestinal
epithelial cells, particularly in the colon. CCR10 and CCL28 are
required for optimal T-cell-dependent IgAplasmablast accumula-
tion in both the small intestine andcolon (Hieshimaet al., 2004;Hu
et al., 2011), as well as for themaintenance of long-lived intestinal
IgA+ PCs and IgA+ memory B cells (Hu et al., 2011). Although the
mechanisms involved in CCR10 induction remain to be deter-
mined, newly generated plasmablasts in caecal patches express
CCR9 and CCR10, whereas those generated in PPs only express
CCR9 (Masahata et al., 2014). As a result, newly generated IgA+
plasmablasts in the caecal patch localize to both the small intes-
tine and colon, whereas those generated in PPs migrate selec-
tively to the small intestine (Masahata et al., 2014).
The titers of luminal IgA and the proportions of IgA-coated
luminal bacteria in both humans and mice are far higher in the
small intestine than in the colon (Bunker et al., 2015) (Figure 4).
Under homeostasis, similar bacterial taxa are represented within
IgA-bound and -unbound bacterial fractions in the small intes-
tine, indicating that most small intestinal commensals can elicit
an IgA response. In contrast, bacterial species that are selec-
tively present in the colon have little IgA coating, suggesting
that commensals in the colon for the most part do not elicit an
IgA response. Interestingly, specific IgA coating of bacteria is
preserved even when titers of unbound luminal IgA are dramat-
ically reduced in the absence of T cells, suggesting that small in-
testinal commensals can efficiently induce T-cell-independent
specific IgA responses and that most unbound IgA is dependent
on T cells and specific to non-microbial antigens (Bunker et al.,
2015). Nevertheless, there is clear evidence that certain
commensals induce T-cell-dependent IgA (Palm et al., 2014)
that can participate in bacterial coating and promote microbial
diversity (for a review, see Pabst et al., 2016). Why certain
commensals are capable of promoting T-cell-dependent IgA is
currently unclear, although an ability to interact with the mucosal
surface could be one contributing factor.
Development and Maturation of Adaptive Immune Cells
in the Intestine
Postnatal development of adaptive immune cells occurs rapidly af-
ter birth. Very few abTCR+T cells are present in themouse intestine
Figure 4. Impact of Environmental Signals
on the Regionalized Generation and
Distribution of IgA PCs
(A) Luminal concentrations of SIgA and the pro-
portions of IgA-bound bacteria are higher in the
small intestine than in the colon. Bacteria that are
selectively present in the colon show little IgA
coating, suggesting that most commensal-spe-
cific IgA responses take place in the small intes-
tine. IgA plasmablast recruitment to the small in-
testine is mediated by CCR9 and CCR10 and that
to the colon is mediated by CCR10. The CCR9-
CCL25 axis appears to play a dominant role in IgA+
plasmablast accumulation to the small intestine
and most likely underlies the largely non-over-
lapping distribution of dominant IgA plasma cell
clones between the small intestine and colon.
(B) Under homeostasis, B cells activated in intes-
tinal inductive sites preferentially differentiate into
IgA plasmablasts. TGFb signaling in B cells is
essential for IgA class switching in vivo. Bac-
terial-dependent MyD88 signaling in CD11c+ cells
induces iNOS to promote TGFbRII expression
on B cells. Bacterial-dependent MyD88 signaling
in T cells promotes TFH generation in GALTs,
enhancing T-cell-dependent IgA responses.
SCFAs act directly on B cells to enhance their
cellular metabolism and support B cell differenti-
ation and antibody production. GALT DCs are
imprinted with the ability to generate RA via direct
RA signaling and potentially through acetate-
induced GPR43-dependent signals. RA from DCs,
and potentially other cells, acts directly on B cells
to promote IgA class switching and induce CCR9
expression on newly generated plasmablasts.
IgA+ plasmablasts generated in PPs are induced
to express CCR9, whereas those generated in the
caecal patch appear to express both CCR10 and
CCR9. As a result, PP-derived plasmablasts
localize to the small intestine, whereas caecal-
patch-derived plasmablasts can gain access to
both the small intestinal and colon. The mecha-
nisms underlying CCR10 induction on IgA+ plas-
mablasts remain unclear.
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2015b). Themajority of the T cells that appear in the early phase are
thymic-derived CD4+abTCR+ T cells that home to early PPs,
whereas CD4+ T cell recruitment to the LP takes place between
days 11 and 28. Another wave of T cells arrives after weaning and
is mostly composed of CD8ab+TCRab+ T cells, although there is
somecontribution fromCD8aa+TCRab+ andCD4+CD8aa+TCRab+
T cells. The very early influx of CD4+ T cells to the neonatal gut is
independent of microbial and TLR signals but requires b7-integ-
rin-dependent pathways. Despite ongoing microbial colonization,
these early CD4+abTCR+ T cells retain a naive phenotype through
a pathway involving both maternal SIgA and Treg cells (Torow
et al., 2015a; Torow et al., 2015b).After birth, B cell numbers increase
steadily until 3 weeks, when they stabilize
(Torow et al., 2015b). Although the bone
marrow is the main site for postnatal B
cell development, the small intestinal LP
of young mice harbors Rag-expressing
immature B cells that perform V(D)J
recombination and receptor editing
locally in response to microbial coloniza-tion (Wesemann et al., 2013). The colon also harbors small
numbers of these cells, but they are absent fromPPs. These cells
could help to shape the pre-immune repertoire, potentially to
negatively (or positively) select against bacterial reactivity, and
the dramatic decrease in their presence in the LP after weaning
would suggest a limited window for this to occur. It is unclear
whether an equivalent population exists in the neonatal
human gut.
Microbial colonization of the intestine stimulates B cell class-
switch recombination, primarily to IgA, in the PPs and ILFs. In
mice, maturation of the mucosal IgA response is inhibited by
the presence of maternal SIgA, and IgA+ PCs do not appear
in the LP until after weaning (Harris et al., 2006). MaternalImmunity 46, April 18, 2017 541
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development of a mucosal TFH cell response in neonatal
mice, which limits GC B cell responses in early life (Koch
et al., 2016). In humans, despite the presence of ILFs at birth
and a rapid influx of B cells after birth, the development of a
mucosal IgA response is also delayed until after 1 month, and
this delay correlates with reduced expression of APRIL and
its receptors TACI and BCMA, but not AID, in the GALTs (Gus-
tafson et al., 2014).
Relevance for Disease Susceptibility Later in Life
Hippocrates once stated that ‘‘all disease begins in the gut.’’
Indeed, the intestinal microbiota contributes to host immunity,
and proper development of the immune landscape within the
intestine is of critical importance to decreasing susceptibility to
diseases that affect both the gastrointestinal tract and systemic
sites. As discussed above, the immune landscape within the in-
testine starts to take shape during fetal life but reaches full matu-
rity only after birth with guidance by exogenous signals from the
microbiota and diet. This dynamic phase in early life represents a
critical window whereby proper or improper immune develop-
ment can affect resistance or susceptibility, respectively, to
diseases later in life. The development of intestinal lymphoid tis-
sues and innate and adaptive immunity early in life defines this
neonatal window.
The impact of improper immune development during this
critical window and the elucidation of underlying mechanisms
have best been illustrated in mouse models together with the
use of gnotobiotics. Microbial colonization of adult germ-free
mice does not lead to the same level of immune maturation as
colonization of neonates, suggesting that exposure to the micro-
biota must occur within a neonatal window in order to properly
imprint host immunity and homeostasis (El Aidy et al., 2013).
However, germ-free mice do not just have an immature im-
mune system—they also display signs of immune dysregulation.
Germ-free mice harbor increased numbers of iNKT cells in both
the lung and colon, leading to increased susceptibility to inflam-
mation in both tissues (Olszak et al., 2012). Importantly, coloniza-
tion before weaning is necessary for inhibiting the accumulation
of these cells and protecting from inflammatory disease later
in life, illustrating the need for microbial education during this
critical window (Olszak et al., 2012). Germ-free mice also
display increased serum IgE levels and increased susceptibility
to anaphylaxis (Cahenzli et al., 2013). Neonatal colonization
with a relatively diverse microbiota suppresses IgE induction
and protects from allergy (Cahenzli et al., 2013). The requirement
for a diverse microbiota suggests either that multiple microbes
are necessary for the provision of a full range of immune educa-
tional cues or that a keystonemicrobial species normally present
in a diverse microbial community is missing. Further evidence
for a critical window is illustrated by the increased susceptibility
to a variety of diseases in mice that received antibiotics in
early life. Administration of clinical doses of select antibiotics
to neonatal, but not adult, mice led to enhanced susceptibility
to experimental allergic asthma, which was linked to a reduction
in the number of colonic Treg cells and an increase in IgE (Russell
et al., 2012; Russell et al., 2013). In another study, antibiotic
treatment during early life led to an increased sensitivity to
food allergy via depletion of beneficial Clostridia spp., and542 Immunity 46, April 18, 2017supplementation stimulated IL-22 production, leading to an
enhanced epithelial barrier and reduced bacterial translocation
(Stefka et al., 2014).
The impact of antibiotic use is not limited to Th2-cell-mediated
immunity. In the non-obese diabetic (NOD) mouse model of type
1 diabetes (T1D), pulses of antibiotics administered in early life
altered the composition and metabolism of the gut microbiome
and led to changes in T cell populations and gene expression
in the small intestine, which accelerated the onset of T1D (Liva-
nos et al., 2016). Antibiotic treatment during pregnancy can also
alter the development of T1D in the offspring by changing the in-
testinal immune landscape (Hu et al., 2015; Tormo-Badia et al.,
2014), such that different antibiotic treatments give different
effects (Hu et al., 2016). Prenatal antibiotic delivery of vancomy-
cin accelerated T1D and increased the numbers of Th17 and
IFNg+ CD8+ T cells in the PPs, whereas neomycin treatment pro-
tected from T1D and induced tolerogenic antigen-presenting
cells (Hu et al., 2016).
Early-life antibiotic use can also affect host metabolism, lead-
ing to alterations in adiposity, hepatic metabolism, metabolic
hormones, and long-term development of adipose tissue, lean
muscle, and bone (Cho et al., 2012; Cox et al., 2014) or acceler-
ating body weight and bone growth (Nobel et al., 2015). How-
ever, in these studies, it is not clear whether this was mediated
through alterations in the intestinal immune landscape or directly
through altered microbial metabolites.
Although changes during the neonatal window are induced
most profoundly by microbial changes, alterations in diet during
this critical window can also change the intestinal immune land-
scape and affect health. Vitamin A supplementation in neonatal
mice can promote early induction of oral tolerance by decreasing
gut permeability and increasing Th1 cell responses (Turfkruyer
et al., 2016). Given that maternal retinoid supplementation can
also increase GALT induction in utero (van de Pavert et al.,
2014) and maternal dietary supplementation with AhR ligands
can shape intestinal ILC3 populations (Gomez de Ag€uero
et al., 2016), the maternal diet could play a strong role in setting
the stage for proper development of the intestinal immune
landscape.
A similar critical window in early life in humans is also likely,
although identifying the mechanisms involved is more difficult.
The intestinal immune landscape in humans also undergoes dy-
namic developmental changes in the first few months after birth
and could reflect a critical window for immune imprinting that
has life-long effects. Although the intestinal microbial community
does not stabilize in humans until about 3 years of age (Yassour
et al., 2016; Yatsunenko et al., 2012), the precise age of the crit-
ical window in infants is not yet clear. Antibiotic use during the
prenatal period or the first years of life is associated with an
increased risk of asthma, allergic disease, and atopic dermatitis
(Marra et al., 2009; Martel et al., 2009; Murk et al., 2011; Racibor-
ski et al., 2012; Risnes et al., 2011; Stensballe et al., 2013). The
microbiome is also implicated in susceptibility to T1D (for a
review, see Paun et al., 2017). Changes in the microbiome in
T1D can precede the onset of T1D (Kostic et al., 2015), and
infants at risk of developing T1D have been found to harbor a
distinct LPS that inhibits immune responsiveness (Vatanen
et al., 2016), highlighting a potential role for the intestinal
immune landscape in early life. Whether these altered disease
Immunity
Reviewsusceptibilities were due to changes in the intestinal immune
landscape that then affected disease phenotypes at systemic
sites is difficult to assess in humans. It is tempting to speculate
that alterations in intestinal T cell phenotypes through antigen-
specific recognition of bacterial components might play a role
in setting the threshold for disease susceptibility (Tai et al., 2016).
Concluding Remarks
The intestinal immune system shows remarkable heterogeneity
along the length of the gut, reflecting regional differences in
intestinal function and site-specific intrinsic and environmental
factors. Alterations in the development of the intestinal immune
landscape, especially during a neonatal window, can have far-
reaching effects and could affect susceptibility to multiple
diseases later in life. Such changes can be mediated by antibi-
otics in early life, which alters the intestinal microbiota and leads
to improper or insufficient immune development, or through die-
tary changes that act either indirectly through alterations in the
microbiota ormicrobial metabolism (Tan et al., 2016a; Trompette
et al., 2014) or directly through an impact on immune cells.
Collectively, the findings described above suggest that specific
alterations in diet and/or antibiotic usage could provide novel
therapeutic opportunities for reducing disease susceptibility or
progression. Before such possibilities can be realized, further
mechanistic studies are required for understanding the full
impact of environmental conditioning on mucosal and systemic
immune system development and functionality. For example, a
direct role for RA or AhR ligands on different cells types and at
different intestinal sites requires clarification. Additionally,
state-of-the-art mapping of human intestinal immune compart-
ments under different conditions and ages is necessary for fully
realizing the translational possibilities of these findings.
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